BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20696698)

  • 1. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.
    Irla M; Küpfer N; Suter T; Lissilaa R; Benkhoucha M; Skupsky J; Lalive PH; Fontana A; Reith W; Hugues S
    J Exp Med; 2010 Aug; 207(9):1891-905. PubMed ID: 20696698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.
    Loschko J; Heink S; Hackl D; Dudziak D; Reindl W; Korn T; Krug AB
    J Immunol; 2011 Dec; 187(12):6346-56. PubMed ID: 22079988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
    Lippens C; Duraes FV; Dubrot J; Brighouse D; Lacroix M; Irla M; Aubry-Lachainaye JP; Reith W; Mandl JN; Hugues S
    J Autoimmun; 2016 Dec; 75():39-49. PubMed ID: 27470005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.
    Parker Harp CR; Archambault AS; Sim J; Ferris ST; Mikesell RJ; Koni PA; Shimoda M; Linington C; Russell JH; Wu GF
    J Immunol; 2015 Jun; 194(11):5077-84. PubMed ID: 25895531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses.
    Archambault AS; Carrero JA; Barnett LG; McGee NG; Sim J; Wright JO; Raabe T; Chen P; Ding H; Allenspach EJ; Dragatsis I; Laufer TM; Wu GF
    J Immunol; 2013 Jul; 191(2):545-50. PubMed ID: 23772037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.
    Wu GF; Shindler KS; Allenspach EJ; Stephen TL; Thomas HL; Mikesell RJ; Cross AH; Laufer TM
    J Autoimmun; 2011 Feb; 36(1):56-64. PubMed ID: 21095100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.
    Sage AP; Murphy D; Maffia P; Masters LM; Sabir SR; Baker LL; Cambrook H; Finigan AJ; Ait-Oufella H; Grassia G; Harrison JE; Ludewig B; Reith W; Hansson GK; Reizis B; Hugues S; Mallat Z
    Circulation; 2014 Oct; 130(16):1363-73. PubMed ID: 25223984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE; Ruddle NH
    J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
    Turley DM; Miller SD
    J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.
    Koyama M; Hashimoto D; Aoyama K; Matsuoka K; Karube K; Niiro H; Harada M; Tanimoto M; Akashi K; Teshima T
    Blood; 2009 Feb; 113(9):2088-95. PubMed ID: 19144988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells.
    Moffat JM; Cheong WS; Villadangos JA; Mintern JD; Netter HJ
    Vaccine; 2013 Apr; 31(18):2310-6. PubMed ID: 23473776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation.
    Mundt S; Mrdjen D; Utz SG; Greter M; Schreiner B; Becher B
    Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30679199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
    Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
    J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.
    Mouriès J; Moron G; Schlecht G; Escriou N; Dadaglio G; Leclerc C
    Blood; 2008 Nov; 112(9):3713-22. PubMed ID: 18698004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.
    Ioannou M; Alissafi T; Boon L; Boumpas D; Verginis P
    J Immunol; 2013 Mar; 190(6):2631-40. PubMed ID: 23382560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
    Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
    J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo.
    Valdez Y; Mah W; Winslow MM; Xu L; Ling P; Townsend SE
    J Exp Med; 2002 Mar; 195(6):683-94. PubMed ID: 11901195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.